The Chemours closed at $13.79 on Nov 4, up 5.35%, 50.6% below its 52-week closing high. Volume of 4.0M shares was 1.70× its 20-day average (above normal).
Split-adjusted performance: -2.1% over one month, -41.7% over six months, +8.8% over one year.
In the quarter ended Jun 30, 2026, revenue was $1.59B, down 1.5% from a year earlier, with a net margin of -17.2%.
Short interest was 14.9M shares at the Oct 15 settlement, down 3.5% from the prior report (9.9% of float, 6.6 days to cover).